Barclays PLC Amgen Inc Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $109 Million - $119 Million	351,300 New	351,300 $113 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $45.9 Million - $55.4 Million	170,800 Added 65.29%	432,400 $123 Million
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $45.6 Million - $51.4 Million	-178,200 Reduced 40.52%	261,600 $75.3 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $55.7 Million - $69.2 Million	254,800 Added 137.73%	439,800 $118 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $2.27 Million - $2.69 Million	-10,600 Reduced 5.42%	185,000 $41.1 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $36.4 Million - $44.3 Million	161,000 Added 465.32%	195,600 $47.3 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $7.92 Million - $10.1 Million	34,600 New	34,600 $9.09 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $1.96 Million - $2.18 Million	8,400 Added 42.0%	28,400 $6.92 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $7.88 Million - $9.18 Million	-35,500 Reduced 63.96%	20,000 $4.98 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $2.1 Million - $2.5 Million	9,700 Added 21.18%	55,500 $12.8 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $2.47 Million - $3.03 Million	-12,500 Reduced 21.44%	45,800 $10.8 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $31 Million - $41.1 Million	-170,200 Reduced 74.49%	58,300 $11.8 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $1.57 Million - $2.02 Million	8,300 Added 3.77%	228,500 $55.1 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $43.4 Million - $52 Million	-249,400 Reduced 53.11%	220,200 $42.6 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $14.3 Million - $16.7 Million	85,500 Added 22.26%	469,600 $86.5 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $17.7 Million - $19.9 Million	97,700 Added 34.11%	384,100 $73 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $16.6 Million - $19.4 Million	93,100 Added 48.16%	286,400 $55.8 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $2.72 Million - $3.07 Million	14,700 Added 8.23%	193,300 $40.1 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $10.4 Million - $11.7 Million	-62,900 Reduced 26.05%	178,600 $33 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $16.7 Million - $19.5 Million	98,400 Added 68.76%	241,500 $41.2 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $3.63 Million - $4.05 Million	21,500 Added 17.68%	143,100 $24.9 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $20.3 Million - $23.2 Million	121,600	121,600 $22.7 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account